New Owner
Jazz Pharmaceuticals - Celator Pharmaceuticals
Jazz Pharmaceuticals acquires Celator Pharmaceuticals
Announced: May 31, 2016
Type: Acquisition
Disposition: Subsidiary
Terms: Cash & Stock
Status: Complete
Amount: $ 1,500,000,000
